3rd Oligonucleotide CMC & Analytical Development Summit

Exclusively dedicated to uniting AD, QC, and CMC leaders the 3rd Oligonucleotide CMC & Analytical Development Summit is the only industry-led meeting solving your impurity, regulatory, and cost-efficiency challenges in this rapidly evolving field.

Across the three days, you’ll get the chance to hear from KOLs like Ionis Pharmaceuticals, AstraZeneca, and CAMP4 Therapeutics as the present their data-driven case studies on managing quality, regulatory affairs, and cost-efficient manufacturing.

Deep dive into the major challenges of streamlining analytical tools, process development, and look towards greener chemistries to ensure global uptake of oligonucleotide drugs.

This isn’t just an event, it’s an investment in the future of your teams’ technical capabilities. Bringing together siRNA, mRNA, ASO, oligo and oligo-conjugate developers, this definitive summit fosters comprehensive development, ensuring the resilience and longevity of this rapidly advancing modality.

Join us this August to assess the field, take back actionable insights to your team, and realize the potential of oligonucleotide therapeutics for prevalent diseases and improved market acceptance.

Event highlights:

  • 3 interactive workshops across CMC consideration, oligo-conjugate analytical and detection methods, and how to establish a robust control strategy
  • 18 data-driven case studies from complex oligo synthesis to scale-up and quality control. This is your end-to-end guide for oligo commercialization
  • 100+ industry experts across Analytical Development, CMC and QC teams in attendance, allowing you to connect, benchmark and strive towards common goals together

Expert speakers include:

  • Angela Tsai, Senior Manager – Collaboration & External Innovation, Sanofi
    George Bou-Assaf, Associate Director, Biogen
    Huijun Tian, Director, Analytical Development & Quality Control, QurAlis
    Isaiah Cedillo, Assistant Director – Manufacturing & Operations, Ionis Pharmaceuticals
    Janine Tom, Senior Principal Scientist, Amgen
    Satya Kuchimanchi, Senior Vice President, Technical Operations, Chemistry, Manufacturing & Controls, CAMP4 Therapeutics

100+ Industry Experts | 3 Interactive Workshops | 20% Off Group Discounts | Data-Driven Case Studies

To know more visit: https://ter.li/eptndw

Comments (0)
Add Comment